Manoj Bob Kusuma

Manoj Bob Kusuma

Auto-generated profile, based on publicly available information

Manoj Bob Kusuma

Bioanalytical Research Department, Lupin Bio-Research Center, Pashan, Pune 411021, Maharashtra State, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Chromatography B
Verified
Journal Article
Closed access
MKManoj Bob Kusuma
Manoj Bob Kusuma
RKRavisekhar Kashibhatta
Ravisekhar Kashibhatta
AGAnil Gavande
Anil Gavande
RKRavi Kiran
Ravi Kiran
SJSandeep Jagtap
Sandeep Jagtap
KBKrishnamurthy Bhat
Krishnamurthy Bhat

29 July 2021 in Journal of Chromatography B
Verified
Journal Article
Closed access
MKManoj Bob Kusuma
Manoj Bob Kusuma
RKRavisekhar Kashibhatta
Ravisekhar Kashibhatta
SJSandeep S. Jagtap
Sandeep S. Jagtap
VNVijay Nadawade
Vijay Nadawade
SASuresh Adsul
Suresh Adsul
PVPraveen Vithala
Praveen Vithala

18 October 2026 in Bioanalysis
Verified
Journal Article
Closed access
VCVikas Chandnani
Vikas Chandnani
STSanjay Tiwari
Sanjay Tiwari
MBManoj Bob
Manoj Bob
APAmol Pawar
Amol Pawar
SKSuhas Khandave
Suhas Khandave
MSMuddukrishna badamane sathyanarayana
Muddukrishna badamane sathyanarayana
1. Biologic medicines have transformed the therapeutic landscape for many chronic and severe diseases by enabling highly specific targeting of disease pathways. Biologic products encompass a broad ...

9 February 2022 in Journal of Chromatography B
Verified
Journal Article
Closed access
MKManoj Bob Kusuma
Manoj Bob Kusuma
RKRavisekhar Kashibhatta
Ravisekhar Kashibhatta
AGAnil Gavande
Anil Gavande
RKRavi Kiran
Ravi Kiran
SJSandeep Jagtap
Sandeep Jagtap
KBKrishnamurthy Bhat
Krishnamurthy Bhat

9 March 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
VCVikas Chandnani
Vikas Chandnani
STSanjay Tiwari
Sanjay Tiwari
MBManoj Bob
Manoj Bob
APAmol Pawar
Amol Pawar
SKSuhas Khandave
Suhas Khandave
MSMuddukrishna badamane sathyanarayana
Muddukrishna badamane sathyanarayana
Precise quantitative determination of Vascular Endothelial Growth Factor (VEGF) in human plasma is critical for pharmacodynamic (PD) evaluation of anti-VEGF therapeutics. In this study, we developed and optimized two immunoassay platforms, including the enzyme-linked immunosorbent assay (ELISA) and the Meso Scale Discovery (MSD), for estimating VEGF. A direct sandwich ELISA was validated to quantify pharmacodynamic biomarker VEGF in human plasma using the Human VEGF Quantikine Kit, demonstrating a quantification range of 62.5–2000.0 pg/mL and a sensitivity of 47.5 pg/mL. In parallel, a sandwich electrochemiluminescence (ECL) assay was developed using the V-PLEX Plus Human VEGF Kit on the MSD platform, achieving a lower quantification range of 7.7–562.0 pg/mL. Comparative analysis revealed that MSD ECL detection with Sulfo Tag labeling outperformed traditional colorimetric ELISA in terms of signal amplification and dynamic range, making it a valuable tool for PD biomarker analysis. Findings underscore the importance of early platform selection to ensure robust, fit-for-purpose biomarker quantification for clinical pharmacology studies and regulatory submissions.

9 February 2022 in Journal of Chromatography B
Verified
Journal Article
Closed access
MKManoj Bob Kusuma
Manoj Bob Kusuma
RKRavisekhar Kashibhatta
Ravisekhar Kashibhatta
SJSandeep S. Jagtap
Sandeep S. Jagtap
VNVijay Nadawade
Vijay Nadawade
SASuresh Adsul
Suresh Adsul
PVPraveen Vithala
Praveen Vithala